Benjamin Tehrani
Foot & Ankle Surgery · Los Angeles, CANPI 1285993451
Payments from drug & device makers
Across 59 payments — averaging $105.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Micromed Inc$557
- Biotissue Holdings Inc.$547
- Vital Orthopedics LLC$527
- Acell, Inc.$342
- Integra Lifesciences Corporation$180
- plus $540 from 14 others
What the payments were for
- Travel & lodging$2,20635%
- Food & beverage$1,39422%
- Education$2,63042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 15 | $3,536 |
| Micromed Inc | 1 | $557 |
| Biotissue Holdings Inc. | 3 | $547 |
| Vital Orthopedics LLC | 12 | $527 |
| Acell, Inc. | 4 | $342 |
| Integra Lifesciences Corporation | 7 | $180 |
| Smith+Nephew | 4 | $98 |
| Stryker | 1 | $89 |
| Medtronic | 1 | $73 |
| Cardiovascular Systems Inc. | 1 | $51 |
| Surgenex LLC | 1 | $41 |
| Bioventus LLC | 1 | $28 |
| KCI USA, Inc. | 1 | $24 |
| Solventum Corporation | 1 | $24 |
| Abbott | 1 | $23 |
| Organogenesis Inc. | 1 | $22 |
| Amgen | 1 | $21 |
| Amniox Medical, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Zimmer Biomet | 1 | $14 |
How this compares
$6,230 in reported general payments places this provider in the 75th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 184 | $9,631 |
| Diclofenac Sodium | 38 | $6,413 |
| Clotrimazole | 148 | $4,164 |
| Ciclopirox | 48 | $1,143 |
| Cephalexin | 15 | $266 |
| Meloxicam | 36 | $164 |
| Gabapentin | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Los Angeles
- Felix SigalLos Angeles$2.2M
- Eric TanLos Angeles$447K
- Timothy CharltonLos Angeles$125K
- Suzette LeeLos Angeles$86K
- Christopher KiddLos Angeles$60K
- John ZimmermanBakersfield$4.6M
- Eric GizaSacramento$3.7M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2.1M
- Michael CoughlinSan Francisco$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.